back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:44 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,175,000 | |
| Filed 2025-05-01 15:54 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,402,778 | |
| Filed 2025-05-01 15:53 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
500,000 | |
| Filed 2025-03-20 11:51 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
4,902,778 | |
| Filed 2025-03-20 11:51 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
4,402,778 | |
| Filed 2025-02-11 13:02 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
||
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
||
| Filed 2025-02-11 13:02 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
2,075,000 | |
| Filed 2025-02-11 13:01 Tx date 2025-02-07 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
1,000,000 | |
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,575,000 | |
| Filed 2024-10-30 16:26 Tx date 2024-10-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
1,500,000 | |
| Filed 2024-07-30 10:45 Tx date 2024-07-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
2,000,000 | |
| Filed 2024-07-19 14:20 Tx date 2024-07-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
||
| Filed 2024-07-19 14:20 Tx date 2024-07-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,000,000 vol |
2,000,000 | |
| Filed 2024-07-19 14:19 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-17 16:48 Tx date 2024-05-14 |
$PSYC
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
875,000 | |
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+277,778 vol $0.18 each |
3,902,778 | |
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+138,889 vol |
138,889 | |
| Filed 2024-04-19 14:56 Tx date 2023-02-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
0 | |
| Filed 2023-03-28 21:26 Tx date 2023-03-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,500
+100,000 vol $0.185 each |
250,000 |